Spyridon Filis

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM Therapy for chronic hepatitis C (HCV) has mainly been evaluated in large clinical, select population, trials. We sought to evaluate whether prognostic factors of therapeutic response are similar(More)
  • 1